Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
Condition(s):Anti- VGF Inhibitor; Diabetic Macular Edema; Diabetic RetinopathyLast Updated:September 6, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Anti- VGF Inhibitor; Diabetic Macular Edema; Diabetic RetinopathyLast Updated:September 6, 2013Completed
Condition(s):Proliferative Diabetic RetinopathyLast Updated:December 6, 2011Unknown status
Condition(s):PDRLast Updated:December 7, 2011Completed
Condition(s):Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular EdemaLast Updated:January 8, 2021Completed
Condition(s):Proliferative Diabetic RetinopathyLast Updated:March 5, 2014Withdrawn
Condition(s):Diabetic Macular OedemaLast Updated:December 24, 2014Completed
Condition(s):Diabetic Macular EdemaLast Updated:July 16, 2013Completed
Condition(s):Branch Retinal Vein OcclusionLast Updated:September 12, 2014Completed
Condition(s):Macular DegenerationLast Updated:October 2, 2015Completed
Condition(s):Myopic Choroidal Neovascular MembraneLast Updated:September 2, 2015Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.